We reveal that monocytes in EBV-HLH act as key effector cells in the inflammatory storm and identify a new activated monocyte subpopulation: indoleamine 2,3-dioxygenase 1 (IDO1)+ monocytes. The gene discussed is IDO1; the disease is hemophagocytic syndrome.